Molecular biology of amyotrophic lateral sclerosis: insights from genetics
暂无分享,去创建一个
[1] Robert H. Brown,et al. Caspase-3 Cleaves and Inactivates the Glutamate Transporter EAAT2* , 2006, Journal of Biological Chemistry.
[2] Sergio Cocozza,et al. Spastic Paraplegia and OXPHOS Impairment Caused by Mutations in Paraplegin, a Nuclear-Encoded Mitochondrial Metalloprotease , 1998, Cell.
[3] S. Ennis,et al. A novel candidate region for ALS on chromosome 14q11.2 , 2004, Neurology.
[4] D. Figlewicz,et al. Aggregation of Mutant Cu/Zn Superoxide Dismutase Proteins in a Culture Model of ALS , 1997, Journal of neuropathology and experimental neurology.
[5] D. Macgowan,et al. An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy , 2001, Neurology.
[6] Robert H. Brown,et al. An intersubunit disulfide bond prevents in vitro aggregation of a superoxide dismutase-1 mutant linked to familial amytrophic lateral sclerosis. , 2004, Biochemistry.
[7] N. Bresolin,et al. The first ALS2 missense mutation associated with JPLS reveals new aspects of alsin biological function. , 2006, Brain : a journal of neurology.
[8] Zuoshang Xu,et al. ALS-associated mutant SOD1G93A causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomes , 2003, BMC Neuroscience.
[9] E. Bigio,et al. Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[10] J. Fink,et al. NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6). , 2003, American journal of human genetics.
[11] B. Rubin,et al. Familial dysautonomia is caused by mutations of the IKAP gene. , 2001, American journal of human genetics.
[12] Bertrand Fontaine,et al. Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia , 1999, Nature Genetics.
[13] T. Shows,et al. Fine Assignment of 3-Hexosaminidase A ar-Subunit on 15823-q 24 by High Resolution In Situ Hybridization , 2006 .
[14] J. Morrison,et al. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[15] V. Meininger,et al. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. , 1994, Human molecular genetics.
[16] A. Munnich,et al. Neurological phenotype in Waardenburg syndrome type 4 correlates with novel SOX10 truncating mutations and expression in developing brain. , 2000, American journal of human genetics.
[17] D. Huylebroeck,et al. Slowed conduction and thin myelination of peripheral nerves associated with mutant rho Guanine-nucleotide exchange factor 10. , 2003, American journal of human genetics.
[18] M. Pericak-Vance,et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis , 2001, Nature Genetics.
[19] Ahmet Hoke,et al. Loss of ALS2 Function Is Insufficient to Trigger Motor Neuron Degeneration in Knock-Out Mice But Predisposes Neurons to Oxidative Stress , 2005, The Journal of Neuroscience.
[20] Hiroshi Nishimune,et al. Motoneuron Death Triggered by a Specific Pathway Downstream of Fas Potentiation by ALS-Linked SOD1 Mutations , 2002, Neuron.
[21] J. Lupski,et al. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies , 1998, Nature Genetics.
[22] D. Turnbull,et al. Motor neuron disease in a patient with a mitochondrial tRNAIle mutation , 2006, Annals of neurology.
[23] A Al-Chalabi,et al. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. , 1999, Human molecular genetics.
[24] Robert H. Brown,et al. SPTLC1 is mutated in hereditary sensory neuropathy, type 1 , 2001, Nature Genetics.
[25] J. Powell,et al. Copper and zinc levels in familial amyotrophic lateral sclerosis patients with cuznsod gene mutations , 1997, Annals of neurology.
[26] 金蔵 孝介. Alsin, the product of ALS2 gene, suppresses SOD1 mutant neurotoxicity through RhoGEF domain by interacting with SOD1 mutants , 2005 .
[27] M. Brodsky,et al. Heterozygous mutations of the kinesin KIF21A in congenital fibrosis of the extraocular muscles type 1 (CFEOM1) , 2003, Nature Genetics.
[28] J. Lupski,et al. Charcot-Marie-Tooth disease type 1A: molecular mechanisms of gene dosage and point mutation underlying a common inherited peripheral neuropathy. , 1991, International journal of neurology.
[29] P K Thomas,et al. N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. , 2000, American journal of human genetics.
[30] P. Andersen,et al. Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia. , 1997, Brain : a journal of neurology.
[31] J. Elliott. Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. , 2001, Brain research. Molecular brain research.
[32] Mark P Mattson,et al. Alzheimer's Presenilin 1 Mutations Impair Kinesin-Based Axonal Transport , 2003, The Journal of Neuroscience.
[33] Aldo Quattrone,et al. Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2 , 2000, Nature Genetics.
[34] L. Greensmith,et al. A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice , 2005, The Journal of cell biology.
[35] L. Bruijn,et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. , 1998, Science.
[36] J. Kurtzke. Risk factors in amyotrophic lateral sclerosis. , 1991, Advances in neurology.
[37] P. Hedera,et al. Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia , 2001, Nature Genetics.
[38] P. Andersen,et al. Overloading of Stable and Exclusion of Unstable Human Superoxide Dismutase-1 Variants in Mitochondria of Murine Amyotrophic Lateral Sclerosis Models , 2006, The Journal of Neuroscience.
[39] F. Joó,et al. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophc lateral sclerosis , 1996, Annals of neurology.
[40] L. Greensmith,et al. Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model , 2005, Nature Medicine.
[41] P. Bork,et al. SPG20 is mutated in Troyer syndrome, an hereditary spastic paraplegia , 2002, Nature Genetics.
[42] Robert H. Brown,et al. A novel locus for familial amyotrophic lateral sclerosis, on chromosome 18q. , 2002, American journal of human genetics.
[43] J. Goldy,et al. Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C , 2003, Neurology.
[44] N. Hirokawa,et al. Charcot-Marie-Tooth Disease Type 2A Caused by Mutation in a Microtubule Motor KIF1Bβ , 2001, Cell.
[45] G. Kollias,et al. Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia , 2006, Science.
[46] P. Carmeliet,et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death , 2003, Nature Genetics.
[47] I. Fridovich,et al. Amyotrophic lateral sclerosis: A proposed mechanism , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[48] J. Trojanowski,et al. Neurofilaments and Orthograde Transport Are Reduced in Ventral Root Axons of Transgenic Mice that Express Human SOD1 with a G93A Mutation , 1997, The Journal of cell biology.
[49] Peter M Andersen,et al. Systematically perturbed folding patterns of amyotrophic lateral sclerosis (ALS)-associated SOD1 mutants. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[50] O. Evgrafov,et al. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. , 2000, American journal of human genetics.
[51] P. Bergh,et al. Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome , 2004, Nature Genetics.
[52] D. Borchelt,et al. Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. , 2003, Human molecular genetics.
[53] K. Narasimhan. Signaling myopia , 1999, Nature Neuroscience.
[54] A. Bush. Is ALS caused by an altered oxidative activity of mutant superoxide dismutase? , 2002, Nature Neuroscience.
[55] Robert W. Taylor,et al. Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis. , 2002, Brain : a journal of neurology.
[56] S. Sasaki,et al. Impairment of fast axonal transport in the proximal axons of anterior horn neurons in amyotrophic lateral sclerosis , 1996, Neurology.
[57] A. Levey,et al. Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis , 1995, Annals of neurology.
[58] Lin Jin,et al. Aberrant RNA Processing in a Neurodegenerative Disease: the Cause for Absent EAAT2, a Glutamate Transporter, in Amyotrophic Lateral Sclerosis , 1998, Neuron.
[59] Robert H. Brown,et al. Mice deficient in the Rab5 guanine nucleotide exchange factor ALS2/alsin exhibit age-dependent neurological deficits and altered endosome trafficking. , 2006, Human molecular genetics.
[60] N. Mazarakis,et al. Therapeutic gene silencing in neurological disorders, using interfering RNA , 2005, Journal of Molecular Medicine.
[61] D. Borchelt,et al. High Molecular Weight Complexes of Mutant Superoxide Dismutase 1: Age-Dependent and Tissue-Specific Accumulation , 2002, Neurobiology of Disease.
[62] S M Leber,et al. Periaxin mutations cause recessive Dejerine-Sottas neuropathy. , 2001, American journal of human genetics.
[63] J. Slade,et al. Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn superoxide dismutase gene: pathological and immunocytochemical changes , 1996, Acta Neuropathologica.
[64] V. La Bella,et al. The role of calcium‐binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis , 1994, Annals of neurology.
[65] W. Robberecht,et al. Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy , 2004, Nature Genetics.
[66] J. Rothstein,et al. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS) , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[67] J. Busciglio,et al. Fast axonal transport misregulation and Alzheimer’s Disease , 2002, NeuroMolecular Medicine.
[68] John Mitchell,et al. A new familial amyotrophic lateral sclerosis locus on chromosome 16q12.1-16q12.2. , 2003, American journal of human genetics.
[69] Robert H. Brown,et al. SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter , 1999, Nature Neuroscience.
[70] P. Stieg,et al. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. , 2000, Science.
[71] C. Guégan,et al. Programmed cell death in amyotrophic lateral sclerosis. , 2003, The Journal of clinical investigation.
[72] G. Rosoklija,et al. Recruitment of the Mitochondrial-Dependent Apoptotic Pathway in Amyotrophic Lateral Sclerosis , 2001, The Journal of Neuroscience.
[73] S. Petri,et al. Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu/Zn‐superoxide dismutase mutant mice , 2006, Journal of neurochemistry.
[74] Shuh Narumiya,et al. ALS2, a novel guanine nucleotide exchange factor for the small GTPase Rab5, is implicated in endosomal dynamics. , 2003, Human molecular genetics.
[75] M. Pericak-Vance,et al. A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). , 2002, American journal of human genetics.
[76] G. McKhann,et al. Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[77] R. Nixon,et al. Defective Neurofilament Transport in Mouse Models of Amyotrophic Lateral Sclerosis: A Review , 2003, Neurochemical Research.
[78] P. Andersen,et al. Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models. , 2006, Brain : a journal of neurology.
[79] M. Beal,et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury , 1996, Nature Genetics.
[80] H. Hartung,et al. Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. , 2003, American journal of human genetics.
[81] V. Silani,et al. Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity , 2001, Journal of the Neurological Sciences.
[82] D. Kastner,et al. Haplotypes and DNA sequence variation within and surrounding the transthyretin gene: genotype–phenotype correlations in familial amyloid polyneuropathy (V30M) in Portugal and Sweden , 2004, European Journal of Human Genetics.
[83] T. Gillingwater,et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. , 2004, American journal of human genetics.
[84] D. Price,et al. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[85] M. Lupi,et al. Neurodegeneration induced by complex I inhibition in a cellular model of familial amyotrophic lateral sclerosis , 2006, Brain Research Bulletin.
[86] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[87] J. McCord. Mutant mice, Cu,Zn superoxide dismutase, and motor neuron degeneration. , 1994, Science.
[88] Timothy A. Miller,et al. Virus‐delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis , 2005, Annals of neurology.
[89] L. Sandkuyl,et al. Tissue-specific splicing mutation in acute intermittent porphyria. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[90] J. Bouchard,et al. Erratum: The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum (Nature Genetics (2002) 32(384-392)) , 2002 .
[91] J. Coyle,et al. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis , 1990, Annals of neurology.
[92] Carsten Bergmann,et al. Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. , 2003, Human molecular genetics.
[93] D. W. Mulder. Clinical limits of amyotrophic lateral sclerosis. , 1982, Advances in neurology.
[94] Massimo Zeviani,et al. Cytochrome c Oxidase subunit I microdeletion in a patient with motor neuron disease , 1998, Annals of neurology.
[95] Yasushi Hiraoka,et al. Mutations in Dynein Link Motor Neuron Degeneration to Defects in Retrograde Transport , 2003, Science.
[96] S. Locke. Clinical Neurology , 1953, Progress in neurology and psychiatry.
[97] A. Ludolph,et al. A dynein mutation attenuates motor neuron degeneration in SOD1G93A mice , 2006, Experimental Neurology.
[98] H. Hartung,et al. Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. , 2003, American journal of human genetics.
[99] K. Fischbeck,et al. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. , 2003, American journal of human genetics.
[100] A. Dürr,et al. Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. , 2002, American journal of human genetics.
[101] M. Beal,et al. Mutated Human SOD1 Causes Dysfunction of Oxidative Phosphorylation in Mitochondria of Transgenic Mice* , 2002, The Journal of Biological Chemistry.
[102] L. Bruijn,et al. Therapeutic targets for amyotrophic lateral sclerosis: current treatments and prospects for more effective therapies , 2006, Expert review of neurotherapeutics.
[103] D. Borchelt,et al. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA , 2005, Neurobiology of Disease.
[104] D. Bredesen,et al. Altered Reactivity of Superoxide Dismutase in Familial Amyotrophic Lateral Sclerosis , 1996, Science.
[105] A. Al-Chalabi,et al. Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relatives , 2005, Neurology.
[106] J. Haines,et al. Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. , 2000, JAMA.
[107] Ole Gredal,et al. Toxicity of Familial ALS-Linked SOD1 Mutants from Selective Recruitment to Spinal Mitochondria , 2004, Neuron.
[108] J. Kong,et al. Massive Mitochondrial Degeneration in Motor Neurons Triggers the Onset of Amyotrophic Lateral Sclerosis in Mice Expressing a Mutant SOD1 , 1998, The Journal of Neuroscience.
[109] E. Fisher,et al. An integrated genetic, radiation hybrid, physical and transcription map of a region of distal mouse chromosome 12, including an imprinted locus and the 'Legs at odd angles' (Loa) mutation. , 2002, Gene.
[110] E. Seeberg,et al. Mutant Huntingtin Impairs Axonal Trafficking in Mammalian Neurons In Vivo and In Vitro , 2004, Molecular and Cellular Biology.
[111] J. Thevelein,et al. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy , 2006, Nature Genetics.
[112] H. Horvitz,et al. Identification of three novel mutations in the gene for Cu Zn superoxide dismutase in patients with familial amyotrophic lateral sclerosis , 1995, Neuromuscular Disorders.
[113] J. Bouchard,et al. The K–Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum , 2002, Nature Genetics.
[114] J. Slade,et al. Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS) , 1998, Neuroreport.
[115] C. Andres,et al. Abnormal SMN1 gene copy number is a susceptibility factor for amyotrophic lateral sclerosis , 2002, Annals of neurology.
[116] H. Moser,et al. Familial spastic paraparesis , 1985, Neurology.
[117] J. Piette,et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 , 1999, Nature Genetics.
[118] K. Abe,et al. Ultrastructural study of mitochondria in the spinal cord of transgenic mice with a G93A mutant SOD1 gene , 2004, Acta Neuropathologica.
[119] G. Sobue,et al. Mitochondrial Localization of Mutant Superoxide Dismutase 1 Triggers Caspase-dependent Cell Death in a Cellular Model of Familial Amyotrophic Lateral Sclerosis* , 2002, The Journal of Biological Chemistry.
[120] K. Domschke,et al. Giant axonal neuropathy (GAN): Case report and two novel mutations in the gigaxonin gene , 2002, Neurology.
[121] A. Munnich,et al. X–linked spastic paraplegia and Pelizaeus–Merzbacher disease are allelic disorders at the proteolipid protein locus , 1994, Nature Genetics.
[122] D. Cleveland,et al. Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[123] M. Cudkowicz,et al. Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene , 1998, Annals of neurology.
[124] H. Cross,et al. Maspardin is mutated in mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia. , 2003, American journal of human genetics.
[125] M. Kavanaugh,et al. Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[126] R. Stevenson,et al. X–linked spastic paraplegia (SPG1), MASA syndrome and X–linked hydrocephalus result from mutations in the L1 gene , 1994, Nature Genetics.
[127] W. Snider,et al. Restricted Expression of G86R Cu/Zn Superoxide Dismutase in Astrocytes Results in Astrocytosis But Does Not Cause Motoneuron Degeneration , 2000, The Journal of Neuroscience.
[128] D. Borchelt,et al. Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[129] P. Ince,et al. Calcium‐permeable α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionic acid receptors: A molecular determinant of selective vulnerability in amyotrophic lateral sclerosis , 1997 .
[130] J. Rothstein,et al. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. , 1992, The New England journal of medicine.
[131] K. Hensley,et al. Journal of Neuroinflammation Primary Glia Expressing the G93a-sod1 Mutation Present a Neuroinflammatory Phenotype and Provide a Cellular System for Studies of Glial Inflammation , 2022 .
[132] Impaired retrograde axonal transport of adenovirus-mediated E. coli LacZ gene in the mice carrying mutant SOD1 gene , 2001, Neuroscience Letters.
[133] T. Wienker,et al. Mutations in the gene encoding immunoglobulin μ-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1 , 2001, Nature Genetics.
[134] R. Kalb,et al. Mutant superoxide dismutase disrupts cytoplasmic dynein in motor neurons , 2005, Neuroreport.
[135] D. Howland,et al. Disruption of Dynein/Dynactin Inhibits Axonal Transport in Motor Neurons Causing Late-Onset Progressive Degeneration , 2002, Neuron.
[136] C. Wijmenga,et al. Lack of association between VEGF polymorphisms and ALS in a Dutch population , 2005, Neurology.
[137] K. Abe,et al. Impairment of axonal transport in the axon hillock and the initial segment of anterior horn neurons in transgenic mice with a G93A mutant SOD1 gene , 2005, Acta Neuropathologica.
[138] B. Pettmann,et al. Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[139] H. Horvitz,et al. A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia , 2006, Neurology.
[140] A. Afifi,et al. Ultrastructure of atrophic muscle in amyotrophic lateral sclerosis , 1966, Neurology.
[141] Shin J. Oh,et al. Mutant dynactin in motor neuron disease , 2003, Nature Genetics.
[142] M Nakagawa,et al. Rapid disease progression correlates with instability of mutant SOD1 in familial ALS , 2005, Neurology.
[143] M. Dubois‐Dauphin,et al. Delaying Caspase Activation by Bcl-2: A Clue to Disease Retardation in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis , 2000, The Journal of Neuroscience.
[144] N. Laing,et al. Toxic mutants in Charcot's sclerosis , 1995, Nature.
[145] C. Henderson,et al. Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS , 2005, Nature Medicine.
[146] J. Wadiche,et al. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[147] F. Menzies,et al. Mitochondrial involvement in amyotrophic lateral sclerosis , 2002, Neurochemistry International.
[148] V. Timmerman,et al. Molecular genetics of distal hereditary motor neuropathies. , 2004, Human molecular genetics.
[149] D. Cleveland,et al. Determinants of rapid disease progression in ALS , 2005, Neurology.
[150] M. Kavanaugh,et al. An excitatory amino-acid transporter with properties of a ligand-gated chloride channel , 1995, Nature.
[151] Zuoshang Xu,et al. Mutant Cu, Zn Superoxide Dismutase that Causes Motoneuron Degeneration Is Present in Mitochondria in the CNS , 2002, The Journal of Neuroscience.
[152] Zuoshang Xu,et al. Mitochondrial electron transport chain complex dysfunction in a transgenic mouse model for amyotrophic lateral sclerosis , 2002, Journal of neurochemistry.
[153] T. Koepsell,et al. Incidence of amyotrophic lateral sclerosis in three counties in western Washington state , 1996, Neurology.
[154] Robert H. Brown,et al. RNA interference-mediated silencing of mutant superoxide dismutase rescues cyclosporin A-induced death in cultured neuroblastoma cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[155] Betty Y. S. Kim,et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice , 2002, Nature.
[156] S. Appel,et al. Immune reactivity in a mouse model of familial ALS correlates with disease progression , 2001, Neurology.
[157] Robert H. Brown,et al. Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes. , 2003, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[158] K. Fischbeck,et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy , 1991, Nature.
[159] J. Weissenbach,et al. Identification and characterization of a spinal muscular atrophy-determining gene , 1995, Cell.
[160] M. Gurney,et al. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[161] A. F. Soleng,et al. A thorny question: how does activity maintain dendritic spines? , 1999, Nature Neuroscience.
[162] C. Stewart,et al. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. , 2002, American journal of human genetics.
[163] J S Beckman,et al. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. , 1999, Science.
[164] Holger Hummerich,et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia , 2005, Nature Genetics.
[165] K. Fischbeck,et al. Connexin mutations in X-linked Charcot-Marie-Tooth disease. , 1993, Science.
[166] Minh N. H. Nguyen,et al. Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice , 2003, Science.
[167] F. Baas,et al. Homozygous deletion of the survival motor neuron 2 gene is a prognostic factor in sporadic ALS , 2001, Neurology.
[168] R. Morimoto,et al. Huntingtin and Mutant SOD1 Form Aggregate Structures with Distinct Molecular Properties in Human Cells* , 2006, Journal of Biological Chemistry.
[169] M. Gurney,et al. Protein Oxidative Damage in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis , 1998, Journal of neurochemistry.
[170] D. Styne. The Regulation of Pubertal Growth , 2003, Hormone Research in Paediatrics.
[171] A. Fluharty,et al. Metachromatic leukodystrophy caused by a partial cerebroside sulfatase defect , 1982, Clinical genetics.
[172] F. Gage,et al. Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model , 2003, Science.
[173] B. Trapp,et al. The neuroprotective factor Wlds does not attenuate mutant SOD1-mediated motor neuron disease , 2007, NeuroMolecular Medicine.
[174] Kurtzke Jf. Risk factors in amyotrophic lateral sclerosis. , 1991 .
[175] S. Züchner,et al. Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy. , 2003, American journal of human genetics.
[176] W. Kunz,et al. Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis , 1998, Journal of the Neurological Sciences.
[177] D. Borchelt,et al. Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[178] E. Bertini,et al. Unstable mutants in the peripheral endosomal membrane component ALS2 cause early-onset motor neuron disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[179] A. Pramatarova,et al. Neuron-Specific Expression of Mutant Superoxide Dismutase 1 in Transgenic Mice Does Not Lead to Motor Impairment , 2001, The Journal of Neuroscience.
[180] G. Másson,et al. A new mutation of the lamin A/C gene leading to autosomal dominant axonal neuropathy, muscular dystrophy, cardiac disease, and leuconychia , 2004, Journal of Medical Genetics.
[181] J. Gilbert,et al. Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21 , 2002, Nature Genetics.
[182] Ole A. Andreassen,et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis , 1999, Nature Medicine.
[183] P. Andersen,et al. Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients. , 1996, Brain : a journal of neurology.
[184] B. Monia,et al. Antisense oligonucleotide therapy for neurodegenerative disease. , 2006, The Journal of clinical investigation.
[185] F. Baas,et al. N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. , 2000, American journal of human genetics.
[186] J. Holstege,et al. Human Cu/Zn Superoxide Dismutase (SOD1) Overexpression in Mice Causes Mitochondrial Vacuolization, Axonal Degeneration, and Premature Motoneuron Death and Accelerates Motoneuron Disease in Mice Expressing a Familial Amyotrophic Lateral Sclerosis Mutant SOD1 , 2000, Neurobiology of Disease.
[187] Noah W. Gray,et al. Alsin Is a Rab5 and Rac1 Guanine Nucleotide Exchange Factor* , 2004, Journal of Biological Chemistry.
[188] H. Tonoki,et al. Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis , 1996, Nature Genetics.
[189] G. Rosoklija,et al. Increased expression of the pro‐inflammatory enzyme cyclooxygenase‐2 in amyotrophic lateral sclerosis , 2001, Annals of neurology.
[190] John W Griffin,et al. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). , 2004, American journal of human genetics.
[191] S. Minotti,et al. Mutant Cu/Zn-Superoxide Dismutase Proteins Have Altered Solubility and Interact with Heat Shock/Stress Proteins in Models of Amyotrophic Lateral Sclerosis* , 2001, The Journal of Biological Chemistry.
[192] P. Watkins,et al. Identification of PAHX, a Refsum disease gene , 1997, Nature Genetics.
[193] I. Glass,et al. Senataxin, the yeast Sen1p orthologue: Characterization of a unique protein in which recessive mutations cause ataxia and dominant mutations cause motor neuron disease , 2006, Neurobiology of Disease.
[194] T. Shows,et al. Fine assignment of beta-hexosaminidase A alpha-subunit on 15q23-q24 by high resolution in situ hybridization. , 1990, The Tohoku journal of experimental medicine.
[195] D L Price,et al. Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[196] M. Pericak-Vance,et al. Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromosome 15q15-q22 markers , 1998, Neurogenetics.
[197] Robert H. Brown,et al. Amyotrophic Lateral Sclerosis-linked Glutamate Transporter Mutant Has Impaired Glutamate Clearance Capacity* , 2001, The Journal of Biological Chemistry.
[198] B. Crain,et al. Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34. , 1998, American journal of human genetics.
[199] M. Koenig,et al. The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy , 2000, Nature Genetics.
[200] A. Sik,et al. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis , 2006, Nature Neuroscience.
[201] H. Horvitz,et al. Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis , 1998, Annals of neurology.
[202] Danqing Zhu,et al. Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease , 2005, Nature Genetics.
[203] D. Borchelt,et al. Axonal Transport of Mutant Superoxide Dismutase 1 and Focal Axonal Abnormalities in the Proximal Axons of Transgenic Mice , 1998, Neurobiology of Disease.
[204] M. Pericak-Vance,et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A , 2004, Nature Genetics.
[205] M. Gurney,et al. Relationship of oxygen radical‐induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS , 1998, Journal of neuroscience research.
[206] M. Dubois‐Dauphin,et al. Bax and Bcl‐2 Interaction in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis , 1999, Journal of neurochemistry.
[207] I. Reynolds,et al. Mitochondrial Depolarization in Glutamate-Stimulated Neurons: An Early Signal Specific to Excitotoxin Exposure , 1996, The Journal of Neuroscience.
[208] M. Carson,et al. ALS, SOD and peroxynitrite , 1993, Nature.
[209] Mulder Dw. Clinical limits of amyotrophic lateral sclerosis. , 1982 .
[210] T. Atsumi. The ultrastructure of intramuscular nerves in amyotrophic lateral sclerosis , 2004, Acta Neuropathologica.
[211] Robert H. Brown,et al. Amyotrophic Lateral Sclerosis-Associated SOD1 Mutant Proteins Bind and Aggregate with Bcl-2 in Spinal Cord Mitochondria , 2004, Neuron.
[212] A. Lengeling,et al. Mutation of Vps54 causes motor neuron disease and defective spermiogenesis in the wobbler mouse , 2005, Nature Genetics.
[213] F. Baas,et al. De-novo mutation in hereditary motor and sensory neuropathy type I , 1992, The Lancet.
[214] Jeffrey D. Rothstein,et al. From charcot to lou gehrig: deciphering selective motor neuron death in als , 2001, Nature Reviews Neuroscience.
[215] M. Pericak-Vance,et al. Erratum: The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis (Nature Genetics (2001) 29 (160-165)) , 2001 .
[216] C. Lewis,et al. Two families with familial amyotrophic lateral sclerosis are linked to a novel locus on chromosome 16q. , 2003, American journal of human genetics.